Maze Therapeutics, Inc. MAZE
32.43 USD +1.23 (+3.94%)
Regular-session close
32.46 +0.03 +0.09%
After hours · Nov 19, 7:43 PM ET
30.69 Day range 32.74
21.95 52-week range 53.65
- YTD
- -21.72%
- 1 year
- -8.75%
Benzinga news
benzinga.com JP Morgan Maintains Overweight on Maze Therapeutics, Lowers Price Target to $51 JP Morgan analyst Anupam Rama maintains Maze Therapeutics (NASDAQ:MAZE) with a Overweight and lowers the price target from $53 to $51.
benzinga.com Wedbush Maintains Outperform on Maze Therapeutics, Raises Price Target to $49 Wedbush analyst Laura Chico maintains Maze Therapeutics (NASDAQ:MAZE) with a Outperform and raises the price target from $48 to $49.
benzinga.com Maze Therapeutics Q3 EPS $(0.79) Misses $(0.77) Estimate Maze Therapeutics (NASDAQ:MAZE) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.77) by 2.6 percent. This is a 19.7 percent decrease over losses of…
benzinga.com Canaccord Genuity Initiates Coverage On Maze Therapeutics with Buy Rating, Announces Price Target of $75 Canaccord Genuity analyst Whitney Ijem initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Buy rating and announces Price Target of $75.
